US Patent Issued to UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, The Trustees of the University of Pennsylvania on Jan. 13 for "Nucleic acids and nucleic acid analogs for treating, preventing, and disrupting pathological polynucleotide-binding protein inclusions" (Pennsylvania Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,412, issued on Jan. 13, was assigned to UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh) and The Trustees of the University of Pennsylvania (Philadelphia).

"Nucleic acids and nucleic acid analogs for treating, preventing, and disrupting pathological polynucleotide-binding protein inclusions" was invented by Christopher Donnelly (Pittsburgh), Jacob Mann (Pittsburgh), James Shorter (Philadelphia), Lin Guo (Philadelphia) and Bede Portz (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods to treat a neurodegenerative disease comprising administering to a subject with a neurodegener...